BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
01.08.23
/
50%
€79.72
Target price
01.08.24
€113.91
Performance (%)
-3.71%
Price
09.07.24
€76.76
Summary
This prediction is currently active. With a performance of -3.71%, the BUY prediction by Morgan_Stanley is trending in the wrong direction. This prediction currently runs until 01.08.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | 0.314% | 0.314% |
iShares Core DAX® | 0.383% | -1.593% |
iShares Nasdaq 100 | 1.543% | 7.530% |
iShares Nikkei 225® | 2.596% | 4.525% |
iShares S&P 500 | 0.573% | 4.229% |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $129.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
1.48%
09.07.24
09.07.24